Ariel Precision Medicine Expands Executive Team with Appointment of Dr. David C. Whitcomb as Chief Scientific Officer Pittsburgh, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held biotechnology company developing innovative solutions for complex chronic disease, announced the...

Mission Cure Holdings, Path BioAnalytics and Ariel Precision Medicine, Launch Unique Research Alliance to Advance Treatments for Pancreatitis New York; Chapel Hill, NC; Pittsburgh, June 15, 2020 (GLOBE NEWSWIRE) -- Mission Cure Holdings, LLC, Path BioAnalytics, Inc. and Ariel Precision Medicine, Inc. jointly announced the creation of a...

Ariel Precision Medicine Receives Prestigious Tech 50 Award from Pittsburgh Technology Council Pittsburgh, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held integrated genomics and digital health company developing innovative solutions for complex chronic...

Ariel Precision Medicine Named Life Sciences PA Emerging Company of the Year Pittsburgh, March 19, 2019 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held, clinically integrated, genomics and health technology company developing innovative solutions for...

Ariel Precision Medicine Inc. Launches New Genomic Tools for Early Diagnosis, Personalized Management of Pancreatic Diseases Pittsburgh, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held integrated genomics and digital health company developing innovative solutions for complex chronic...